Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

TMI Blog

Home

1998 (10) TMI 156

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... per : S.K. Bhatnagar, Vice President]. The appellants have sent a letter, dated 16-6-1997 briefly summerising their pleas and requesting that the case may be decided in their absence on the basis of their written submissions. Accordingly we have gone through the records and heard ld. SDR. In the written submissions, briefly, the appellants have mainly stated in their written submission that .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... acanazole cream were classifiable under sub-heading 3003.19 and Estolin was classifiable under sub-heading 3003.11 of Chapter 30 of the Schedule to the Central Excise Tariff Act, 1985 as it stood during the years 1986-87 and 1987-88. 3. Patent or proprietary medicaments falling under sub-heading 3003.19 and manufactured using Neomycin and Miconazole as ingredients were exempted from the whole o .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... payment of duty. 4. A show cause notice issued by Superintendent seeking to deny exemption on Estolin on the ground that the ingredient used for this formulation, Erythromycin Estolate, was a salt cum ester of Erythromycin which was not specified in the tariff entry below sub-heading 3003.11 was adjudicated by the Assistant Collector and the show cause notice was withdrawn in his speaking order .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... lts cum Easters of Erythromycin which is not specified in Chapter 3003.11 all the notification are effective from the date on which they have issued. In this case Notification No. 455/86, dated 21-11-1986 is effective from 21-11-1986 and retrospective effect is not mentioned in the said Notification. 7. We have considered the above submissions. We find that Heading 3003.11 reads as follows :- .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... d its salts; Rifampicin; Tetracycline Hydrochloride; Chloroquine diphosphate; Doxycycline, its salts and esters; Erythromycin, its salts and esters; Mebendazole. Nil It is clear from the above that Erythromycin and its salts and esters are explicitly covered by this heading. They are therefore required to be classified charged nil rate of duty accordingly. 8. So far as Notifica .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

 

 

 

 

Quick Updates:Latest Updates